MARC

LEADER 00000cam a2200000ui 4500
001 p2325031
005 20240212122500.0
006 m o d
007 cr |n|||||||||
008 151010s2000 dcu o 000 0 eng d
019 |a 990411917 
020 |a 9780309593885 
020 |a 0309593883 
020 |a 0309068282 
020 |a 9780309068284 
035 |a (OCoLC)923261685  |z (OCoLC)990411917 
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d MERUC  |d OCLCQ  |d LIP  |d OCLCF  |d XFH  |d OCLCQ  |d OCLCO  |d ZCU  |d OCLCO  |d OCLCA  |d ICG  |d OCLCQ  |d DKC  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCA  |d OCLCO  |d OCLCQ  |d OCL  |d UtOrBLW 
050 4 |a RA413.5.U5.M36325 2000eb 
082 0 4 |a 362.104258 
100 1 |a Staff, Institute of Medicine. 
245 1 0 |a Managed Care Systems and Emerging Infections :  |b Challenges and Opportunities for Strengthening Surveillance. 
260 |a Washington :  |b National Academies Press,  |c 2000. 
300 |a 1 online resource (128 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a ""6 Drug Formularies "" 
505 0 |a Managed Care Systems and Emerging Infections -- Copyright -- REVIEWERS -- Preface -- Contents -- Summary -- BASIC AND CLINICAL RESEARCH -- CLINICAL PRACTICE GUIDELINES -- SURVEILLANCE AND MONITORING -- EDUCATION AND OUTREACH -- DRUG FORMULARIES -- 1 Introduction -- BACKGROUND -- ABOUT THE WORKSHOP AND ORGANIZATION OF THE WORKSHOP SUMMARY -- 2 Conducting Basic and Clinical Research in the Managed Care Setting -- PERSPECTIVE OF ASSOCIATION OF AMERICAN MEDICAL COLLEGES ON BASIC AND CLINICAL RESEARCH 
505 8 |a OPPORTUNITIES FOR POPULATION-BASED CLINICAL RESEARCH USING DATA FROM MANAGED CARE ORGANIZATIONSCONDUCTING CLINICAL RESEARCH WITHIN MANAGED CARE ORGANIZATIONS -- NIH ACTIVITIES RELATED TO CLINICAL RESEARCH AND MANAGED CARE -- SUMMARY OF CHALLENGES AND OPPORTUNITIES -- Supporting the Functions of Academic Health Centers -- Ensuring Adequate Databases for Clinical Research -- Exploiting the Unique Advantages of Managed Care for Surveillance and Research -- Promoting Collaboration -- Summary -- 3 Clinical Practice Guidelines 
505 8 |a CLINICAL PRACTICE GUIDELINES FOR EMERGING INFECTIONS AND MANAGED CAREREALITIES OF IMPLEMENTING GUIDELINES -- MAKING GUIDELINES INSTRUMENTAL: THEORY VERSUS PRACTICE -- SUMMARY OF CHALLENGES AND OPPORTUNITIES -- Promoting Adoption and Use of Guidelines in Managed Care Organizations -- Involving Clinicians in Guideline Development and Implementation -- The Need for Systemwide, Standardized Guidelines -- Promoting Professional and Public Education -- Summary -- 4 Surveillance and Monitoring -- AN EMPLOYER'S PERSPECTIVE 
505 8 |a MANAGED CARE AND INFECTIOUS DISEASE SURVEILLANCE: OPPORTUNITIES FOR COLLABORATIONCOLLABORATIVE SURVEILLANCE EFFORTS AND MONITORING OF DATA -- LATTER DAY SAINTS HOSPITAL'S SYSTEM -- LABORATORY-BASED REPORTING AND MANAGING ENCOUNTER-LEVEL DATA -- LABORATORY-BASED REPORTING ISSUES -- LEGAL CONCERNS -- SUMMARY OF CHALLENGES AND OPPORTUNITIES -- Understanding Professional Roles in Surveillance and Monitoring -- Ensuring Availability of Data -- Promoting Sharing of Data -- Tracking Nosocomial Infections -- Accurate Reporting of Encounter-Level Data 
505 8 |a Overcoming Structural BarriersSummary -- 5 Education and Outreach -- COORDINATING HEALTH PLAN RESEARCH AND EDUCATIONAL EFFORTS -- IMPACTS OF MANAGED CARE SYSTEM'S EDUCATIONAL EFFORTS ON CONTROL OF ANTIBIOTIC USE -- EDUCATION AND OUTREACH PERSPECTIVES OF THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES -- MANAGED CARE SYSTEMS AND EMERGING INFECTIONS: EDUCATION AND OUTREACH -- SUMMARY OF CHALLENGES AND OPPORTUNITIES -- Promote Professional Education Efforts -- Encourage Judicious Antibiotic Use -- Invest in Educational Programs -- Summary 
546 |a English. 
588 0 |a Print version record. 
650 0 |a Managed care plans (Medical care)  |0 sh 87004126  
650 0 |a Emerging infectious diseases.  |0 sh2003008316 
650 0 |a Health insurance.  |0 sh 85066932  
650 0 |a National health insurance.  |0 sh 92004306  
650 0 |a Drug resistance.  |0 sh 85039708  
650 0 |a Health services administration.  |0 sh 85059600  
650 0 |a Insurance.  |0 sh 85066802  
650 0 |a Public health.  |0 sh 85108638  
650 0 |a Medical care.  |0 sh 85082871  
650 0 |a Economics.  |0 sh 85040850  
650 0 |a Drug resistance in microorganisms.  |0 sh 85039709  
650 2 |a Insurance, Health.  |0 D007348 
650 2 |a Drug Resistance.  |0 D004351 
650 2 |a Patient Care Management.  |0 D010346 
650 2 |a Health Care Quality, Access, and Evaluation.  |0 D017530 
650 2 |a Public Health Practice.  |0 D015980 
650 2 |a Microbiological Phenomena.  |0 D008827 
650 2 |a Health Services Administration.  |0 D006298 
650 2 |a Insurance.  |0 D007341 
650 2 |a Phenomena and Processes. 
650 2 |a Pharmacological Phenomena.  |0 D000069437 
650 2 |a Public Health.  |0 D011634 
650 2 |a Delivery of Health Care.  |0 D003695 
650 2 |a Environment and Public Health.  |0 D004778 
650 2 |a Financing, Organized.  |0 D005381 
650 2 |a Physiological Phenomena.  |0 D010829 
650 2 |a Economics.  |0 D004467 
650 2 |a Health Care Economics and Organizations.  |0 D004472 
650 2 |a Drug Resistance, Microbial.  |0 D004352 
650 2 |a Communicable Disease Control.  |0 D003140 
650 2 |a Managed Care Programs.  |0 D008329 
650 2 |a Communicable Diseases, Emerging.  |0 D021821 
650 2 |a National Health Programs.  |0 D009313 
650 2 |a Patient Care Management  |x methods.  |0 D010346Q000379 
650 7 |a Medical care.  |2 homoit  |0 homoit0001004 
776 0 8 |i Print version:  |a Staff, Institute of Medicine.  |t Managed Care Systems and Emerging Infections : Challenges and Opportunities for Strengthening Surveillance.  |d Washington : National Academies Press, ©1900  |z 9780309068284 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3376165 
951 |a 2325031 
999 f f |i 34274cbb-ce0c-53bc-bb70-c7c2230d9d6b  |s 19d8633d-3104-53bf-8e95-b83e91198036  |t 0 
952 f f |a Massachusetts College of Pharmacy and Health Sciences  |b Online  |c Online  |d E-Collections  |t 0  |e NCBI  |h Other scheme 
856 4 0 |t 0  |u http://www.ncbi.nlm.nih.gov/books/NBK100178/  |y Full text